DK0387775T3 - Genetisk enhed til inhibering af funktionen af RNA - Google Patents

Genetisk enhed til inhibering af funktionen af RNA

Info

Publication number
DK0387775T3
DK0387775T3 DK90104701.9T DK90104701T DK0387775T3 DK 0387775 T3 DK0387775 T3 DK 0387775T3 DK 90104701 T DK90104701 T DK 90104701T DK 0387775 T3 DK0387775 T3 DK 0387775T3
Authority
DK
Denmark
Prior art keywords
rna
units
inhibiting
unit
genetic
Prior art date
Application number
DK90104701.9T
Other languages
Danish (da)
English (en)
Inventor
Hartmut Dr Beug
Max L Prof-Dr Birnstiel
Matthew Dr Cotten
Ernst Dr Wagner
Harald Dipl-Ing Kandolf
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Application granted granted Critical
Publication of DK0387775T3 publication Critical patent/DK0387775T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/11—Antisense
    • C12N2310/111—Antisense spanning the whole gene, or a large part of it
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/12—Type of nucleic acid catalytic nucleic acids, e.g. ribozymes
    • C12N2310/121—Hammerhead

Landscapes

  • Genetics & Genomics (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK90104701.9T 1989-03-16 1990-03-13 Genetisk enhed til inhibering af funktionen af RNA DK0387775T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AT60989 1989-03-16

Publications (1)

Publication Number Publication Date
DK0387775T3 true DK0387775T3 (da) 1996-11-04

Family

ID=3495118

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90104701.9T DK0387775T3 (da) 1989-03-16 1990-03-13 Genetisk enhed til inhibering af funktionen af RNA

Country Status (20)

Country Link
EP (1) EP0387775B1 (fr)
JP (1) JP3330930B2 (fr)
KR (1) KR900014591A (fr)
AT (1) ATE140961T1 (fr)
AU (1) AU637354B2 (fr)
CA (1) CA2012312C (fr)
DD (1) DD297838A5 (fr)
DE (1) DE59010432D1 (fr)
DK (1) DK0387775T3 (fr)
ES (1) ES2090049T3 (fr)
FI (1) FI105103B (fr)
GR (1) GR3020935T3 (fr)
HU (2) HU215187B (fr)
IE (1) IE74850B1 (fr)
IL (1) IL93754A (fr)
NO (1) NO306623B1 (fr)
NZ (1) NZ232917A (fr)
PT (1) PT93440B (fr)
RU (1) RU2136751C1 (fr)
ZA (1) ZA901973B (fr)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0471796A4 (en) * 1989-05-10 1993-05-05 Sloan Kettering Institute For Cancer Research Stably transformed eucaryotic cells comprising a foreign transcribable dna under the control of a pol iii promoter
DE4091533T (fr) * 1989-08-31 1992-01-30
JP2507895B2 (ja) * 1989-12-19 1996-06-19 工業技術院長 リボザイムの新規合成系
KR930701590A (ko) * 1990-06-19 1993-06-12 알프레드 퍼나트 엔도누클레아제
US6008343A (en) * 1990-06-19 1999-12-28 Gene Shears Pty. Ltd. Nucleotide based endonucleases
CA2093664C (fr) * 1990-10-12 2003-07-29 Fritz Eckstein Ribozymes modifies
DE4104186A1 (de) * 1991-02-12 1992-08-13 Genentech Inc Neue, ueber endozytose in hoehere eukaryotische zellen aufnehmbare, nukleinsaeure enthaltende komplexe
FR2687411A1 (fr) * 1992-02-13 1993-08-20 Nice Sophia Antipolis Universi Vecteur comportant un gene viral transcrit par l'arn polymerase iii, et procede de production intracellulaire d'arn.
WO1993022433A2 (fr) * 1992-04-28 1993-11-11 Frank Andreas Harald Meyer Medicament permettant de traiter l'homme, les animaux et les plantes par therapie genetique, dans le but notamment de bloquer la proliferation de virus et les carcinogenes et procede de fabrication dudit medicament
US5989906A (en) * 1992-05-14 1999-11-23 Ribozyme Pharmaceuticals, Inc. Method and reagent for inhibiting P-glycoprotein (mdr-1-gene)
WO1993023057A1 (fr) * 1992-05-14 1993-11-25 Ribozyme Pharmaceuticals, Inc. Procede et reactif destines a empecher l'evolution du cancer
US5610052A (en) * 1992-08-26 1997-03-11 Ribozyme Pharmaceuticals Inc. Enzymatic RNA with activity to ras
US5827935A (en) * 1992-05-27 1998-10-27 City Of Hope Chimeric tRNAlys -ribozyme molecules
EP0596901B1 (fr) * 1992-05-27 2000-08-09 City Of Hope MOLECULES CHIMERIQUES DE RIBOZYMES D'ARNt LYS
HUT71929A (en) * 1992-06-29 1996-02-28 Gene Shears Pty Ltd Nucleic acids and methods of use thereof for controlling viral pathogens
AU5968994A (en) * 1992-12-16 1994-07-04 Johanna E. Bergmann Agents for the prevention and treatment of human alzheimer's disease
ATE250670T1 (de) * 1993-07-06 2003-10-15 Univ Nice Sophia Antipolis Vektor, enthält ein bei arn-polymerase-iii transcriptes virus-gen
US5837503A (en) * 1993-07-07 1998-11-17 Universite De Nice-Sophia-Antipolis Vector containing viral gene transcribed by RNA polymerase III and methods for use
US5817635A (en) * 1993-08-09 1998-10-06 Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. Modified ribozymes
CA2157015A1 (fr) * 1994-01-24 1995-07-27 John J. Rossi Co-localisation d'une molecule cible et de ses inhibiteurs
DE4424761C1 (de) * 1994-07-04 1995-06-08 Max Planck Gesellschaft Expressionskassette für die Antisense- und die Ribozym-Expression
JPH11506914A (ja) 1995-06-07 1999-06-22 コモンウェルス・サイエンティフィック・アンド・インダストリアル・リサーチ・オーガニゼーション 最適化ミニザイムおよびミニリボザイムおよびその使用
FR2755976B1 (fr) * 1996-11-15 1999-01-15 Idm Immuno Designed Molecules Nouveaux complexes d'acides nucleiques et de polymere substitue par des residus entrainant la destabilisation des membranes cellulaires
US6057156A (en) 1997-01-31 2000-05-02 Robozyme Pharmaceuticals, Inc. Enzymatic nucleic acid treatment of diseases or conditions related to levels of epidermal growth factor receptors
WO1999020753A2 (fr) * 1997-10-21 1999-04-29 Ribozyme Pharmaceuticals, Inc. Formation de liaison peptidique utilisant des catalyseurs d'acide nucleique
US6506559B1 (en) 1997-12-23 2003-01-14 Carnegie Institute Of Washington Genetic inhibition by double-stranded RNA
ATE526406T1 (de) 1998-03-20 2011-10-15 Commw Scient Ind Res Org Kontrolle der genexpression
AUPP249298A0 (en) 1998-03-20 1998-04-23 Ag-Gene Australia Limited Synthetic genes and genetic constructs comprising same I
EP1147204A1 (fr) 1999-01-28 2001-10-24 Medical College Of Georgia Research Institute, Inc. Composition et methode destinees a l'attenuation in vivo et in vitro de l'expression genique utilisant de l'arn double brin
US6423885B1 (en) 1999-08-13 2002-07-23 Commonwealth Scientific And Industrial Research Organization (Csiro) Methods for obtaining modified phenotypes in plant cells
CA2369944A1 (fr) 2001-01-31 2002-07-31 Nucleonics Inc. Utilisation de l'inhibition genetique post-transcriptionnelle pour identifier les sequences d'acides nucleiques qui modulent la fonction d'une cellule
AUPR621501A0 (en) 2001-07-06 2001-08-02 Commonwealth Scientific And Industrial Research Organisation Delivery of ds rna

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4987071A (en) * 1986-12-03 1991-01-22 University Patents, Inc. RNA ribozyme polymerases, dephosphorylases, restriction endoribonucleases and methods

Also Published As

Publication number Publication date
ZA901973B (en) 1991-11-27
PT93440A (pt) 1990-11-07
AU637354B2 (en) 1993-05-27
DE59010432D1 (de) 1996-09-05
ES2090049T3 (es) 1996-10-16
NZ232917A (en) 1997-07-27
EP0387775B1 (fr) 1996-07-31
NO901213D0 (no) 1990-03-15
CA2012312A1 (fr) 1990-09-16
KR900014591A (ko) 1990-10-24
JPH03130080A (ja) 1991-06-03
IL93754A0 (en) 1990-12-23
FI105103B (fi) 2000-06-15
IE900931L (en) 1990-09-16
HUT54206A (en) 1991-01-28
PT93440B (pt) 2001-07-31
GR3020935T3 (en) 1996-12-31
DD297838A5 (de) 1992-01-23
IE74850B1 (en) 1997-08-13
CA2012312C (fr) 2001-08-14
JP3330930B2 (ja) 2002-10-07
IL93754A (en) 1995-12-31
EP0387775A1 (fr) 1990-09-19
AU5130190A (en) 1990-11-01
HU901584D0 (en) 1990-06-28
ATE140961T1 (de) 1996-08-15
NO306623B1 (no) 1999-11-29
NO901213L (no) 1990-09-17
RU2136751C1 (ru) 1999-09-10
HU215187B (hu) 1998-10-28
HU211868A9 (en) 1995-12-28
FI901296A0 (fi) 1990-03-15

Similar Documents

Publication Publication Date Title
DK0387775T3 (da) Genetisk enhed til inhibering af funktionen af RNA
ATE189264T1 (de) Chimärisches oligonukleotid und dessen verwendung zur herstellung von nukleinsäure-transkripten
PT731835E (pt) Oligonucleotidos anti-sentido possuindo actividade inibidora de tumorigenicidade
EP0572287A3 (fr) Utilisation d'oligonucléotides cycliques bicaténaires, contenant le site de liaison d'un facteur de transcription, pour inhiber l'expression de gènes
ATE154029T1 (de) 7-deazapurin modifizierte oligonukleotide
DK0519053T3 (da) Nucleinsyreamplifikation med DNA-afhængig RNA-polymeraseaktivitet hos RNA-replicaser
EP0708829B8 (fr) Composition pharmaceutique comprenant de l'acide nucleique antisens utilise dans la prevention et/ou le traitement de lesions neuronales, de la degenerescence et de la mort cellulaire ainsi que dans le traitement des neoplasmes
Nakashima et al. Proximity of mRNA5′-region and 18S rRNA in eukaryotic initiation complexes
DK1175489T3 (da) Oligonukleotider indeholdende en antisense-sekvens stabiliseret af en sekundær struktur og farmaceutiske præparater indeholdende disse oligonukleotider
DE69921609D1 (de) Ribozymale nukleinsäure die ccr5 oder cxcr4 schneiden
Hatta et al. Mechanisms of the inhibition of reverse transcription by unmodified and modified antisense oligonucleotides
AU6144294A (en) Plant virus resistance conferring polyribozyme and resistant plants producing same
WO1995025801A3 (fr) Replicon viral
AU3956100A (en) Rna polymerase i transcription factor tif-ia
Richardson et al. Identification of upstream sequence components of rho-dependent transcription terminators.
Sugisaki Kinetoplast Minicircles Carrying Guide RNA Genes of Leishmania tarentolae (RESEARCH FACILITY OF NUCLEIC ACIDS)
UA19318A (uk) СПОСІБ ОДЕРЖАHHЯ ЛЮДСЬКОЇ МnО2-ДИСМУТАЗИ